AI-Powered navigation aims to pinpoint tiny lung nodules during surgery

NCT ID NCT07682012

Completed Disease control Sponsor: Tri-Service General Hospital (TSGH) Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests a device called the LungVision system, which uses artificial intelligence to help surgeons locate small lung nodules during minimally invasive surgery. The system combines CT scans with live X-ray images to guide a tool to the nodule, then injects a dye to mark it for removal. The trial involves 14 adults aged 18 to 65 who are already scheduled for lung nodule surgery, and it measures how often the system successfully finds the nodule, how long it takes, and any complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LungVision System (AI-augmented fluoroscopic navigation device)
What this could lead to: If successful, this AI-guided navigation could make lung nodule surgery more precise and reduce the need for extra radiation or preoperative procedures.
What could go wrong: This is a small pilot study with only 14 participants, so results may not apply to everyone. The system's accuracy and safety need confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL CELL-LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma pulmonary coin lesion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, NON-SMALL CELL-LUNG LUNG NEOPLASMS PULMONARY NODULE, SOLITARY

Contacts and locations

Locations

Tri-Service General Hospital

Taipei, Taiwan, 114202, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.